Her-Shyong Shiah

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih‐Hsin Yang, D. Ross Camidge, Cheng‐Ta Yang et al. · Journal of Thoracic Oncology · 2020 · 149 citations · Full text

Pretreated Patients, Novel Therapy, Medicine +8

Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036

Her-Shyong Shiah, Wan-Shu Lee, Shin‐Hun Juang et al. · Biochemical Pharmacology · 2006 · 75 citations

Human Cancer Cells, Mitochondrial Function, Medicine +10

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy

Chiao‐Fang Teng, Han‐Chieh Wu, Hung-Wen Tsai et al. · Hepatology · 2011 · 66 citations · Full text

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent<i>in vitro</i>and<i>in vivo</i>antitumoral activity which involves DNA damage and ataxia telangiectasia–mutated nuclear protein kinase activation

Shin‐Hun Juang, Chia-Chi Lung, Pi-Chen Hsu et al. · Molecular Cancer Therapeutics · 2007 · 65 citations

Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503

Her-Shyong Shiah, Wenli Gao, David C. Baker et al. · Molecular Cancer Therapeutics · 2006 · 60 citations